This week we'll be discussing the recent SCOT trial, which pitting myeloablative autologous stem cell transplant against standard care of cyclophosphamide. Be sure to follow us on Twitter at @EBRheum and checkout @RheumJC for a great online discussion of the trial! Access the paper itself here: https://tinyurl.com/y9xdkvzs